Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small

A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of becoming a reality. Researchers have disclosed that this innovative jab has the potential to eradicate a form of kidney cancer.

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to an experimental, personalized cancer vaccine, researchers reported Feb. 5.

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults.

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer three years after the pioneering treatment.

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

Doctors at Dana-Farber say this personalized vaccine can be given after surgery to remove a tumor and train the body’s immune system to eliminate tumor cells.